Transplantation of allogeneic peripheral blood progenitor cells--the EBMT experience. 1996

N Schmitz, and A Bacigalupo, and M Labopin, and I Majolino, and J P Laporte, and L Brinch, and G Cook, and G Lambertenghi-Deliliers, and A Lange, and C Rozman, and J Garcia-Conde, and J Finke, and A Domingo-Albos, and A Gratwohl
Department of Internal Medicine II, University of Kiel, Germany.

UI MeSH Term Description Entries
D007938 Leukemia A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006) Leucocythaemia,Leucocythemia,Leucocythaemias,Leucocythemias,Leukemias
D008223 Lymphoma A general term for various neoplastic diseases of the lymphoid tissue. Germinoblastoma,Lymphoma, Malignant,Reticulolymphosarcoma,Sarcoma, Germinoblastic,Germinoblastic Sarcoma,Germinoblastic Sarcomas,Germinoblastomas,Lymphomas,Lymphomas, Malignant,Malignant Lymphoma,Malignant Lymphomas,Reticulolymphosarcomas,Sarcomas, Germinoblastic
D008232 Lymphoproliferative Disorders Disorders characterized by proliferation of lymphoid tissue, general or unspecified. Duncan's Syndrome,X-Linked Lymphoproliferative Syndrome,Duncan Disease,Epstein-Barr Virus Infection, Familial Fatal,Epstein-Barr Virus-Induced Lymphoproliferative Disease In Males,Familial Fatal Epstein-Barr Infection,Immunodeficiency 5,Immunodeficiency, X-Linked Progressive Combined Variable,Lymphoproliferative Disease, X-Linked,Lymphoproliferative Syndrome, X-Linked, 1,Purtilo Syndrome,X-Linked Lymphoproliferative Disease,X-Linked Lymphoproliferative Disorder,Disease, Duncan,Disease, X-Linked Lymphoproliferative,Diseases, X-Linked Lymphoproliferative,Disorder, Lymphoproliferative,Disorder, X-Linked Lymphoproliferative,Disorders, Lymphoproliferative,Disorders, X-Linked Lymphoproliferative,Epstein Barr Virus Induced Lymphoproliferative Disease In Males,Epstein Barr Virus Infection, Familial Fatal,Familial Fatal Epstein Barr Infection,Immunodeficiency 5s,Immunodeficiency, X Linked Progressive Combined Variable,Lymphoproliferative Disease, X Linked,Lymphoproliferative Diseases, X-Linked,Lymphoproliferative Disorder,Lymphoproliferative Disorder, X-Linked,Lymphoproliferative Disorders, X-Linked,Lymphoproliferative Syndrome, X-Linked,Lymphoproliferative Syndromes, X-Linked,Purtilo Syndromes,Syndrome, Purtilo,Syndrome, X-Linked Lymphoproliferative,Syndromes, Purtilo,Syndromes, X-Linked Lymphoproliferative,X Linked Lymphoproliferative Disease,X Linked Lymphoproliferative Disorder,X Linked Lymphoproliferative Syndrome,X-Linked Lymphoproliferative Diseases,X-Linked Lymphoproliferative Disorders,X-Linked Lymphoproliferative Syndromes
D008297 Male Males
D008727 Methotrexate An antineoplastic antimetabolite with immunosuppressant properties. It is an inhibitor of TETRAHYDROFOLATE DEHYDROGENASE and prevents the formation of tetrahydrofolate, necessary for synthesis of thymidylate, an essential component of DNA. Amethopterin,Methotrexate Hydrate,Methotrexate Sodium,Methotrexate, (D)-Isomer,Methotrexate, (DL)-Isomer,Methotrexate, Dicesium Salt,Methotrexate, Disodium Salt,Methotrexate, Sodium Salt,Mexate,Dicesium Salt Methotrexate,Hydrate, Methotrexate,Sodium, Methotrexate
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011239 Prednisolone A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states. Di-Adreson-F,Predate,Predonine,Di Adreson F,DiAdresonF
D001782 Blood Donors Individuals supplying blood or blood components for transfer to histocompatible recipients. Blood Donor,Donor, Blood,Donors, Blood
D002066 Busulfan An alkylating agent having a selective immunosuppressive effect on BONE MARROW. It has been used in the palliative treatment of chronic myeloid leukemia (MYELOID LEUKEMIA, CHRONIC), but although symptomatic relief is provided, no permanent remission is brought about. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), busulfan is listed as a known carcinogen. Busulphan,Busulfan Wellcome,Busulfex,Glyzophrol,Myelosan,Mylecytan,Myleran,Myléran,n-Butane-1,3-di(methylsulfonate),Wellcome, Busulfan
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children

Related Publications

N Schmitz, and A Bacigalupo, and M Labopin, and I Majolino, and J P Laporte, and L Brinch, and G Cook, and G Lambertenghi-Deliliers, and A Lange, and C Rozman, and J Garcia-Conde, and J Finke, and A Domingo-Albos, and A Gratwohl
January 1995, Nouvelle revue francaise d'hematologie,
N Schmitz, and A Bacigalupo, and M Labopin, and I Majolino, and J P Laporte, and L Brinch, and G Cook, and G Lambertenghi-Deliliers, and A Lange, and C Rozman, and J Garcia-Conde, and J Finke, and A Domingo-Albos, and A Gratwohl
January 1996, Annals of oncology : official journal of the European Society for Medical Oncology,
N Schmitz, and A Bacigalupo, and M Labopin, and I Majolino, and J P Laporte, and L Brinch, and G Cook, and G Lambertenghi-Deliliers, and A Lange, and C Rozman, and J Garcia-Conde, and J Finke, and A Domingo-Albos, and A Gratwohl
December 1998, Bone marrow transplantation,
N Schmitz, and A Bacigalupo, and M Labopin, and I Majolino, and J P Laporte, and L Brinch, and G Cook, and G Lambertenghi-Deliliers, and A Lange, and C Rozman, and J Garcia-Conde, and J Finke, and A Domingo-Albos, and A Gratwohl
February 1997, Transfusion,
N Schmitz, and A Bacigalupo, and M Labopin, and I Majolino, and J P Laporte, and L Brinch, and G Cook, and G Lambertenghi-Deliliers, and A Lange, and C Rozman, and J Garcia-Conde, and J Finke, and A Domingo-Albos, and A Gratwohl
March 1996, Bone marrow transplantation,
N Schmitz, and A Bacigalupo, and M Labopin, and I Majolino, and J P Laporte, and L Brinch, and G Cook, and G Lambertenghi-Deliliers, and A Lange, and C Rozman, and J Garcia-Conde, and J Finke, and A Domingo-Albos, and A Gratwohl
June 1997, Cytokines, cellular & molecular therapy,
N Schmitz, and A Bacigalupo, and M Labopin, and I Majolino, and J P Laporte, and L Brinch, and G Cook, and G Lambertenghi-Deliliers, and A Lange, and C Rozman, and J Garcia-Conde, and J Finke, and A Domingo-Albos, and A Gratwohl
December 1998, Bone marrow transplantation,
N Schmitz, and A Bacigalupo, and M Labopin, and I Majolino, and J P Laporte, and L Brinch, and G Cook, and G Lambertenghi-Deliliers, and A Lange, and C Rozman, and J Garcia-Conde, and J Finke, and A Domingo-Albos, and A Gratwohl
June 1998, Bone marrow transplantation,
N Schmitz, and A Bacigalupo, and M Labopin, and I Majolino, and J P Laporte, and L Brinch, and G Cook, and G Lambertenghi-Deliliers, and A Lange, and C Rozman, and J Garcia-Conde, and J Finke, and A Domingo-Albos, and A Gratwohl
December 1998, British journal of haematology,
N Schmitz, and A Bacigalupo, and M Labopin, and I Majolino, and J P Laporte, and L Brinch, and G Cook, and G Lambertenghi-Deliliers, and A Lange, and C Rozman, and J Garcia-Conde, and J Finke, and A Domingo-Albos, and A Gratwohl
January 2002, Cancer treatment and research,
Copied contents to your clipboard!